COGT · US market
Cogent Biosciences Inc
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$5.48bnFinancials dated 30 June 2026Price dated 1 October 2026
Core valuation
Calculation inputs
- Trailing earnings
- -US$377.18m
- Latest-quarter run-rate earnings
- -US$385.62m
- Latest fiscal-year earnings
- -US$328.94m
- Trailing revenue
- Unavailable
- Latest-quarter run-rate revenue
- Unavailable
- Latest fiscal-year revenue
- Unavailable
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- FMED · Fidelity Disruptive Medicine ETF2.85% weight · Holdings dated 31 May 2026
- XBI · State Street SPDR S&P Biotech ETF1.06% weight · Holdings dated 21 August 2026
- DNDGX · Dunham Small Cap Growth Fund Class N0.87% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- SHSSX · BlackRock Health Sciences Opportunities Portfolio Institutional Shares0.83% weight · Holdings dated 29 May 2026
- DTSGX · Wilshire Small Company Growth Portfolio Investment Class Shares0.81% weight · Holdings dated 30 June 2026
- APSDX · NYLI Fiera SMID Growth Class R60.68% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- HISCX · Hartford Small Cap Growth HLS Fund Class IA0.66% weight · Holdings dated 30 June 2026
- PGRTX · Principal SmallCap Growth Fund I Institutional Class0.65% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- FSCRX · Fidelity Small Cap Discovery Fund0.62% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- FIMPX · Nuveen Small Cap Growth Opportunities Fund Class I0.62% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 June 2026. Informational research, not investment advice.